Bells Sports Day / fundraiser 2024
We are thrilled to share the incredible success of our recent fundraiser, raising money for the families of the Southport attack.
Thanks to everyone's generosity and support, we have raised an amazing total of £2973.75 🎉
Bells / RelonChem are very proud sponsors of Warrington Rylands U11's
Bells / Relonchem have been proud to be a sponsor and supporter of the Warrington Rylands U11s for a number of years now
2023/24 What a fantastic season for the Warrington Rylands U11s.
With 8 trophies including Nationals to their name in one season(23-24)and only a select few will be able to call themselves National Champions.
Congratulations to all involved!
Bells Healthcare awarded prestigious awards
•This year Bells Healthcare in recognition of all our activities was awarded the prestigious Exporter of the Year award for 2024
•Plus Bells Healthcare were also awarded Outstanding Business of the Year 2024 their top prize
Exciting new Factory Announced in India
As part of Marksans Pharma Ltd we are one of the fastest growing pharmaceutical companies, and we are really pleased to confirm that in October have finalised an agreement to purchase a new manufacturing site in India.
Mark Saldanha Promoter and Managing Director of Marksans Pharma said, “I am excited to share that the acquisition has potential to significantly expand our manufacturing capability and accelerate our core growth strategy. It will supplement our innovative product portfolio, as we plan to begin manufacturing of creams, ointments etc. It is also a testament to our commitment to invest in product innovation, expand capabilities, and drive market share gains. We are confident that this acquisition will lead to a transformational growth journey.”
This new site is 47,500 square meters.
NEW NPD & SMALL-SCALE MANUFACTURING FACILITY
Bells healthcare officially opened a new facility within their Southport site.
The facility, based on the vision / brief given by the MD Sathish Kumar will be used to:
· Manufacture initial submission batches to relevant regulatory bodies
· Manufacture and fill development non-sterile liquid products.
· Manufacture small scale commercial batches.
· This will be a key element for our ongoing NPD programme.
Once the facility was planned, specified, and approved the build was completed in 3 months, The Project Lead, Engineering Manage Malcolm Mitchell together with QA and Engineering handed over the facility to MD Sathish Kumar on 1st November 2021.
